HCAT

Health Catalyst, Inc Common Stock

1.73

USD

0.00

+0.12%

Oct 19, 10:52 UTC -4

Open

HCAT Earnings Reports

Positive Surprise Ratio

HCAT beat 25 of 29 last estimates.

86%

Next Report

Date of Next Report

Nov 10, 2026

Estimate for Q3 26 (Revenue/ EPS)

$56.50M

-$0.04

Implied change from Q2 26 (Revenue/ EPS)

-19.85%

-200.00%

Implied change from Q3 25 (Revenue/ EPS)

-25.97%

-166.67%

Health Catalyst, Inc Common Stock earnings per share and revenue

On Aug 06, 2026, HCAT reported earnings of 0.04 USD per share (EPS) for Q2 26, beating the estimate of 0.03 USD, resulting in a 29.03% surprise. Revenue reached 70.49 million, compared to an expected 70.44 million, with a 0.07% difference. The market reacted with a -25.11% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 10 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 56.50 million USD, implying an decrease of -200.00% EPS, and decrease of -19.85% in Revenue from the last quarter.

FAQ

What were Health Catalyst, Inc Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Health Catalyst, Inc Common Stock reported EPS of $0.04, beating estimates by 29.03%, and revenue of $70.49M, 0.07% above expectations.

How did the market react to Health Catalyst, Inc Common Stock's Q2 2026 earnings?

The stock price moved down -25.11%, changed from $2.31 before the earnings release to $1.73 the day after.

When is Health Catalyst, Inc Common Stock expected to report next?

The next earning report is scheduled for Nov 10, 2026.

What are the forecasts for Health Catalyst, Inc Common Stock's next earnings report?

Based on 10 analysts, Health Catalyst, Inc Common Stock is expected to report EPS of -$0.04 and revenue of $56.50M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.